pl
en
Country
pl
Language
en

Trial design of the impact of modified RBV doses on the efficacy of triple therapy with telaprevir in patients infected with 1 HCV genotype with advanced liver fibrosis with prior treatment failure

Speciality: Infectious diseases
Language : Polski
Broadcast type : Live conference
Duration : 00:13:54
Date: September 28, 2012

Trial design of the impact of modified RBV doses on the efficacy of triple therapy with telaprevir in patients infected with 1 HCV genotype with advanced liver fibrosis with prior treatment failure

Other in: Infectious diseases